首页 | 本学科首页   官方微博 | 高级检索  
     

顺铂为主联合化疗加放疗治疗超长食管癌
引用本文:郝颖坤,刘恩孝. 顺铂为主联合化疗加放疗治疗超长食管癌[J]. 中国肿瘤临床与康复, 1999, 6(1): 62-63
作者姓名:郝颖坤  刘恩孝
作者单位:山西省肿瘤医院
摘    要:目的探讨顺铂为主联合化疗加放疗对病变长度大于8cm食管癌的疗效。方法1988年1月至1991年12月对病变长度大于8cm,不宜行手术治疗的食管癌病人随机分为二组(各60例)治疗,一组采用顺铂、平阳霉素、长春新碱联合化疗后根治性放疗(化放组),一组仅行单纯放射治疗(单放组),进行对比分析。结果化放组与单放组1,3,5年生存率分别为61.7%、30.0%、20.0%与36.7%、10.0%、5.0%,比较均有显著性差异。结论顺铂为主联合化疗后放疗综合治疗是治疗超长食管癌的有效方法。

关 键 词:超长食管癌  顺铂  联合化疗  放疗

Combined chemotherapy including highdose cisplatin and radiotherapy for super long esophageal carcinoma
Rao yingkun,Liu Enxiao,et al.. Combined chemotherapy including highdose cisplatin and radiotherapy for super long esophageal carcinoma[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 1999, 6(1): 62-63
Authors:Rao yingkun  Liu Enxiao  et al.
Affiliation:Rao yingkun,Liu Enxiao,et al. Shanxi Province Tumor Hospitol,Taiyuan 030013
Abstract:Objective To analyze the effect of combined chemotherapy including highdose cisplatin and radiotherapy for super long esophageal carcinoma (>8cm). Materials and Methods 120 patients with super long esophageal carcinoma were randomly divided into two groups from 1988 to 1991. 60 patients received combined chemotherapy (CT) with cisplatin, pingyangmycin and vinblastin followed by radical radiotherapy (RT) (CT RT group). 60 patients received RT along (RT group). Results The 1 ,3 ,5 year survival rates in CT RT group and RT group were 61.7% and 36.7% (P<0.01),30.0% and 10.0%(P<0.01),20.0% and 5.0%(P<0.05). Conclusion It is an efficacious method to super long esophageal carcinoma that combined chemotherapy including highdose cisplatin and radiotherapy.
Keywords:Super long esophageal carcinoma Cisplatin Combined chemotherapy Radiotherapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号